1. Fitzmaurice C, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48.
2. Ghazarian AA, Trabert B, Devesa SS, McGlynn KA. Recent trends in the incidence of testicular germ cell tumors in the united states. Andrology. 2015;3(1):13–8.
3. Xu P, Wang J, Abudurexiti M, Jin S, Wu J, Shen Y, et al. Prognosis of patients with testicular carcinoma is dependent on metastatic site. Front Oncol. 2019;9:1495.
4. International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. International germ cell cancer collaborative group. J Clin Oncol 1997;15(2):594–603.
5. Kavanagh MC, Pakala SR, Hollander DA, O’Brien JM. Choriocarcinoma metastatic to the choroid. Br J Ophthalmol. 2006;90(5):650–2.